Stock Analysis on Net

Amgen Inc. (NASDAQ:AMGN)

$24.99

Price to Operating Profit (P/OP)
since 2005

Microsoft Excel

Calculation

Amgen Inc., P/OP, long-term trends, calculation

Microsoft Excel

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

1 US$

2 Data adjusted for splits and stock dividends.

3 Closing price as at the filing date of Amgen Inc. Annual Report.


The Price to Operating Profit (P/OP) ratio for the analyzed period exhibits considerable fluctuation, though generally trends upward over the long term. Initial values are relatively high, followed by a period of decline, and then a resurgence before stabilizing and increasing again in recent years.

Initial Period (2006-2009)
The P/OP ratio begins at 17.96 and increases to 19.54 before declining sharply to 9.70. This initial decline likely reflects a combination of factors, potentially including market corrections and changes in investor sentiment. The decrease suggests the share price fell more rapidly than operating profit per share during this period.
Stabilization and Moderate Growth (2010-2015)
From 2010 to 2015, the P/OP ratio demonstrates a period of relative stabilization with moderate growth. It fluctuates between approximately 8.79 and 19.13. While there are yearly variations, the ratio generally trends upward, indicating a strengthening relationship between share price and operating profit. The increase to 19.13 in 2015 represents a notable peak within this timeframe.
Recent Trends (2016-2026)
The period from 2016 onwards shows a more consistent upward trend in the P/OP ratio. Starting at 13.07, the ratio generally increases, reaching 21.92 by 2026. This suggests that the market has been increasingly willing to pay a premium for each dollar of operating profit. The most recent values, 19.69, 21.55, and 21.92, indicate a sustained high valuation relative to operating profit. The ratio increased from 13.84 in 2020 to 21.92 in 2026.

Overall, the P/OP ratio demonstrates a cyclical pattern with a long-term upward trajectory. The fluctuations suggest sensitivity to market conditions and investor expectations. The recent increase in the ratio may indicate positive investor sentiment regarding future earnings potential or a broader market revaluation.


Comparison to Competitors

Amgen Inc., P/OP, long-term trends, comparison to competitors

Microsoft Excel

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).